Top 10 Books about Stock Investing to read in 2018. Read more.

IMGN - ImmunoGen

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

IMGN - ImmunoGen

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#4957()/6583

Fri 25'th May 2018

PERIOD 2018-02-26 - 2018-05-25
CHANGE -1.42%
PRICE $10.43
VOLUME
Buy
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Sell

Request Prediction
0.00%
Predict

ImmunoGen Stock Analysis

Technical stock analysis for Fri 25'th May 2018

Sell candidate since 2018-05-25

ImmunoGen fell by -1.42% in the last day from $10.58 to $10.43 The price has been going up and down for this period, and there has been a -1.7% loss for the last 2 weeks. Volume has increased in the last day by 0.59 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.46 million shares bought and sold for approximately $15.21 million.

Shorts 5.58% ( 2018-04-30 )
Cash 612.3 mill
Loans n/a
Beta 2.09
ROA -51.67

Trend

ImmunoGen lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.86% during the next 3 months and, with 90% probability hold a price between $8.26 and $10.86 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. ImmunoGen holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $10.48 and $10.46. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday May 24, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 54 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

ImmunoGen finds support from accumulated volume at $10.32.

Support: $10.32 Price: $10.43 Resistance: $11.01

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.37 (3.64%) between high and low. For the last week, the stock has had a daily average volatility of 3.90%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

ImmunoGen holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Trade IMGN CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL